(Q37764617)

22 August 2017

1 reference

title

Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase (English)

1 reference

22 August 2017

Jean-Yun Chang

1

1 reference

22 August 2017

Ruei-Yu He

2

1 reference

22 August 2017

Hsin-Ping Lin

3

1 reference

22 August 2017

Li-Jin Hsu

4

1 reference

22 August 2017

Feng-Jie Lai

5

1 reference

22 August 2017

Qunying Hong

6

1 reference

22 August 2017

Shean-Jen Chen

7

1 reference

22 August 2017

Nan-Shan Chang

8

1 reference

22 August 2017

publication date

11 June 2010

1 reference

Experimental Biology and Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

235

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

796-804

1 reference

The WW domain: a signalling site in dystrophin?

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Characterization of a novel protein-binding module--the WW domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

A map of WW domain family interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WW domains provide a platform for the assembly of multiprotein networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Common mechanism of ligand recognition by group II/III WW domains: redefining their functional classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WW or WoW: the WW domains in a union of bliss

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Filling out the Hippo pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The Nedd4-like family of E3 ubiquitin ligases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

A common biological mechanism in cancer and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Large common fragile site genes and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WWOX in biological control and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WWOX: its genomics, partners, and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Generation and characterization of mice carrying a conditional allele of the Wwox tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

A spontaneous mutation of the Wwox gene and audiogenic seizures in rats with lethal dwarfism and epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WWOX, the common chromosomal fragile site, FRA16D, cancer gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Alterations of common chromosome fragile sites in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Common chromosomal fragile sites and cancer: focus on FRA16D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Targeted deletion of Wwox reveals a tumor suppressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The WW domain: linking cell signalling to the membrane cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Image-based assessment of growth and signaling changes in cancer cells mediated by direct cell-cell contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Association of Wwox with ErbB4 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Physical association with WWOX suppresses c-Jun transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Cloning and characterization of a small-size peptide Zfra that regulates the cytotoxic function of tumor necrosis factor by interacting with JNK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Expression profiling of UVB response in melanocytes identifies a set of p53-target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

TGF-beta-induced epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Keeping out the bad guys: gateway to cellular target therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Association between cancer and "acid mucopolysaccharides": an old concept comes of age, finally

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Hyaluronan and hyaluronidase in genitourinary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Proteoglycan control of cell movement during wound healing and cancer spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Hyaluronan regulates transforming growth factor-beta1 receptor compartmentalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Surface plasmon-enhanced two-photon fluorescence microscopy for live cell membrane imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Imaging live cell membranes via surface plasmon-enhanced fluorescence and phase microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The alpha2beta1 integrin: a novel collectin/C1q receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The contribution of gC1qR/p33 in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

p53--a Jack of all trades but master of none

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

Transcription-independent p53 apoptosis: an alternative route to death

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The p53 Pathway Encounters the MicroRNA World

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

The tumor suppressor p53: cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2010.009351

21 January 2018

Identifiers

DOI

10.1258/EBM.2010.009351

1 reference

22 August 2017

1 reference